Page last updated: 2024-10-26

valproic acid and Dysarthosis

valproic acid has been researched along with Dysarthosis in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Treatment of chronic daily headache/transformed migraine is challenging, especially when it is complicated by overuse of analgesics, triptans, or both."2.70Intravenous valproate sodium in the treatment of daily headache. ( Karpitskiy, VV; Schwartz, TH; Sohn, RS, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwartz, TH1
Karpitskiy, VV1
Sohn, RS1
Berroya, AG1
McIntyre, J1
Webster, R1
Lah, S1
Sabaz, M1
Lawson, J1
Bleasel, AF1
Bye, AM1

Trials

1 trial available for valproic acid and Dysarthosis

ArticleYear
Intravenous valproate sodium in the treatment of daily headache.
    Headache, 2002, Volume: 42, Issue:6

    Topics: Adolescent; Adult; Analgesics; Cerebellar Ataxia; Chronic Disease; Dose-Response Relationship, Drug;

2002

Other Studies

1 other study available for valproic acid and Dysarthosis

ArticleYear
Speech and language deterioration in benign rolandic epilepsy.
    Journal of child neurology, 2004, Volume: 19, Issue:1

    Topics: Anomia; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Cognition Disorder

2004